2,354 Shares of CME Group Inc. $CME Purchased by StoneRidge PMG Advisors LLC

StoneRidge PMG Advisors LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the 3rd quarter, Holdings Channel.com reports. The firm bought 2,354 shares of the financial services provider’s stock, valued at approximately $617,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Whipplewood Advisors LLC lifted its holdings in CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares in the last quarter. First Community Trust NA purchased a new stake in CME Group during the 3rd quarter valued at approximately $26,000. North Point Portfolio Managers Corp OH purchased a new stake in CME Group during the 3rd quarter valued at approximately $26,000. Main Street Group LTD purchased a new stake in CME Group during the 1st quarter valued at approximately $32,000. Finally, Compass Financial Management LLC grew its holdings in CME Group by 471.4% during the 3rd quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock valued at $31,000 after buying an additional 99 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. UBS Group lifted their price objective on shares of CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a research report on Thursday, October 22nd. TD Cowen upped their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a research report on Monday, October 5th. CLSA set a $367.00 target price on shares of CME Group in a research note on Thursday, October 22nd. Weiss Ratings raised shares of CME Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $314.44.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 10,079 shares of CME Group stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total value of $3,075,606.85. Following the completion of the transaction, the insider owned 21,482 shares in the company, valued at approximately $6,555,232.30. The trade was a 31.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Howard J. Siegel sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $303.00, for a total value of $606,000.00. Following the transaction, the director directly owned 19,873 shares in the company, valued at approximately $6,021,519. This represents a 9.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 32,979 shares of company stock valued at $9,552,762. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $305.89 on Monday. The firm’s 50-day moving average price is $283.10 and its 200-day moving average price is $280.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $109.49 billion, a price-to-earnings ratio of 25.09, a P/E/G ratio of 3.73 and a beta of 0.15. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm’s revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the business posted $2.68 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post 12.34 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be given a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. CME Group’s dividend payout ratio is 42.66%.

CME Group Profile

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.

The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

CME Group was formed in 2007 through the merger of the Chicago Mercantile Exchange and the Chicago Board of Trade, institutions with roots in the 19th century.